Announcement: COVID-19 impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Editors-in-Chief
Jeroen Hoozemans, Amsterdam University Medical Centers, The Netherlands
Jason Huse, University of Texas MD Anderson Cancer Center, USA
Aims and scope
Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques
Why publish with ANC?
- No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
- Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
- Rapid publication: publication within 2 months of submission
- Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
- Open access: enabling it to be read by a much larger set of readers, increasing its visibility
- Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees
Articles
-
-
Meningomyeloencephalitis secondary to Mycobacterium haemophilum infection in AIDS
-
Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
-
Epigenomics and transcriptomics analyses of multiple system atrophy brain tissue supports a role for inflammatory processes in disease pathogenesis
-
Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma
-
Myelin alters the inflammatory phenotype of macrophages by activating PPARs
-
Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study
-
Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice
-
The prion hypothesis in Parkinson's disease: Braak to the future
-
Neuropathology of brain and spinal malformations in a case of monosomy 1p36
Sister journal
ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.
Call for Papers - Open Collections
Featured Article - Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Our latest featured article examines the link between the genetic mutation which causes flushing after alcohol consumption, which occurs in around 8% of the population, and Alzheimer's Disease-related pathology.
Read Mochly-Rosen et al.'s full study here.
EUROTAU Series: Reflections on the Status Quo
EUROTAU is an innovative, collaborative research initiative established to tackle unanswered research questions and the mounting challenges posed by Tauopathies. EUROTAU provides a forum for promoting ambitious, innovative, multi-national and multi-disciplinary collaborative research projects, that: i) combine experimental approaches from fundamental, pre-clinical and/or clinical with computational approaches; ii) perform network analyses in different Tauopathies to elucidate the underlying mechanisms that are common as well as those that are different between them, and iii) will add value to existing research by analyzing diseases across traditional clinical boundaries, thereby gaining deeper understanding of the patho-physiological mechanisms of these disorders.
From the Editors-in-Chief
"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."
Jeroen Hoozemans, co-Editor-in-Chief, ANC
"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand. ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead."
Jason T. Huse, co-Editor-in-Chief, ANC
Advertisement
Follow
Annual Journal Metrics
-
Speed
24 days to first decision for reviewed manuscripts only
13 days to first decision for all manuscripts
37 days from submission to acceptance
23 days from acceptance to publicationCitation Impact
5.883 - 2-Year impact factor
5.860 - 5-Year impact factor
1.754 - Source Normalized Impact per Paper (SNIP)
23.279 - SCImago Journal Rank (SJR)Usage
608,006 downloads
1,581 altmetric mentions
Advertisement
